These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 11483817

  • 1. Rescue use of DNase in critical lung atelectasis and mucus retention in premature neonates.
    El Hassan NO, Chess PR, Huysman MW, Merkus PJ, de Jongste JC.
    Pediatrics; 2001 Aug; 108(2):468-70. PubMed ID: 11483817
    [Abstract] [Full Text] [Related]

  • 2. Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticus.
    Durward A, Forte V, Shemie SD.
    Crit Care Med; 2000 Feb; 28(2):560-2. PubMed ID: 10708200
    [Abstract] [Full Text] [Related]

  • 3. Bronchoscopically administered recombinant human DNase for lobar atelectasis in cystic fibrosis.
    Slattery DM, Waltz DA, Denham B, O'Mahony M, Greally P.
    Pediatr Pulmonol; 2001 May; 31(5):383-8. PubMed ID: 11340685
    [Abstract] [Full Text] [Related]

  • 4. Safety of endotracheal rh DNAse (Pulmozyme) for treatment of pulmonary atelectasis in mechanically ventilated children.
    Boeuf B, Prouix F, Morneau S, Marton D, Lacroix J.
    Pediatr Pulmonol; 1998 Aug; 26(2):147. PubMed ID: 9727769
    [No Abstract] [Full Text] [Related]

  • 5. DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis.
    Merkus PJ, de Hoog M, van Gent R, de Jongste JC.
    Eur Respir J; 2001 Oct; 18(4):734-7. PubMed ID: 11716180
    [Abstract] [Full Text] [Related]

  • 6. Easy removal of a large mucus plug with a flexible paediatric bronchoscope after administration of rhDNase (Pulmozyme).
    Kamin W, Klär-Hlawatsch B, Truebel H.
    Klin Padiatr; 2006 Oct; 218(2):88-91. PubMed ID: 16506110
    [Abstract] [Full Text] [Related]

  • 7. Safety of recombinant human deoxyribonuclease as a rescue treatment for persistent atelectasis in newborns.
    Fedakar A, Aydogdu C, Fedakar A, Ugurlucan M, Bolu S, Iskender M.
    Ann Saudi Med; 2012 Oct; 32(2):131-6. PubMed ID: 22366825
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of nebulized recombinant human DNase as rescue treatment for persistent atelectasis in newborns: case-series.
    Erdeve O, Uras N, Atasay B, Arsan S.
    Croat Med J; 2007 Apr; 48(2):234-9. PubMed ID: 17436388
    [Abstract] [Full Text] [Related]

  • 9. Use of recombinant human DNase in a premature infant with recurrent atelectasis.
    Küpeli S, Teksam O, Dogru D, Yurdakök M.
    Pediatr Int; 2003 Oct; 45(5):584-6. PubMed ID: 14521538
    [No Abstract] [Full Text] [Related]

  • 10. Endotracheal DNase for atelectasis in ventilated neonates.
    MacKinnon R, Wheeler KI, Sokol J.
    J Perinatol; 2011 Dec; 31(12):799-801. PubMed ID: 22124516
    [Abstract] [Full Text] [Related]

  • 11. Human recombinant DNase for mucus plugging in status asthmaticus.
    Greally P.
    Lancet; 1995 Nov 25; 346(8987):1423-4. PubMed ID: 7475833
    [No Abstract] [Full Text] [Related]

  • 12. DNase and atelectasis in non-cystic fibrosis pediatric patients.
    Hendriks T, de Hoog M, Lequin MH, Devos AS, Merkus PJ.
    Crit Care; 2005 Aug 25; 9(4):R351-6. PubMed ID: 16137347
    [Abstract] [Full Text] [Related]

  • 13. Inhaled Dornase alfa (Pulmozyme) as a noninvasive treatment of atelectasis in mechanically ventilated patients.
    Zitter JN, Maldjian P, Brimacombe M, Fennelly KP.
    J Crit Care; 2013 Apr 25; 28(2):218.e1-7. PubMed ID: 23266402
    [Abstract] [Full Text] [Related]

  • 14. Dornase alfa in premature infants with severe respiratory distress and early bronchopulmonary dysplasia.
    Reiter PD, Townsend SF, Velasquez R.
    J Perinatol; 2000 Dec 25; 20(8 Pt 1):530-4. PubMed ID: 11190594
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of lobar atelectasis with bronchoscopically administered recombinant human deoxyribonuclease in cystic fibrosis?
    McLaughlin AM, McGrath E, Barry R, Egan JJ, Gallagher CG.
    Clin Respir J; 2008 Apr 25; 2(2):123-6. PubMed ID: 20298317
    [Abstract] [Full Text] [Related]

  • 16. Dornase alpha in the management of a mechanically ventilated infant with cystic fibrosis.
    Kling S, Gie RP, Riphagen S.
    Pediatr Pulmonol; 1997 Aug 25; 24(2):124-5. PubMed ID: 9292906
    [No Abstract] [Full Text] [Related]

  • 17. Dornase in non-CF.
    Ratjen F.
    Pediatr Pulmonol Suppl; 2004 Aug 25; 26():154-5. PubMed ID: 15029636
    [No Abstract] [Full Text] [Related]

  • 18. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME.
    N Engl J Med; 1994 Sep 08; 331(10):637-42. PubMed ID: 7503821
    [Abstract] [Full Text] [Related]

  • 19. Dornase alpha compared to hypertonic saline for lung atelectasis in critically ill patients.
    Youness HA, Mathews K, Elya MK, Kinasewitz GT, Keddissi JI.
    J Aerosol Med Pulm Drug Deliv; 2012 Dec 08; 25(6):342-8. PubMed ID: 22413805
    [Abstract] [Full Text] [Related]

  • 20. The use of pulmonary clearance medications in the acutely ill patient.
    Papacostas MF, Luckett P, Hupp S.
    Expert Rev Respir Med; 2017 Oct 08; 11(10):815-826. PubMed ID: 28780895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.